Kathryn Moseley

1.7k total citations
26 papers, 833 citations indexed

About

Kathryn Moseley is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, Kathryn Moseley has authored 26 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Biochemistry, 15 papers in Physiology and 12 papers in Molecular Biology. Recurrent topics in Kathryn Moseley's work include Metabolism and Genetic Disorders (20 papers), Diet and metabolism studies (11 papers) and Mitochondrial Function and Pathology (8 papers). Kathryn Moseley is often cited by papers focused on Metabolism and Genetic Disorders (20 papers), Diet and metabolism studies (11 papers) and Mitochondrial Function and Pathology (8 papers). Kathryn Moseley collaborates with scholars based in United States, Denmark and Japan. Kathryn Moseley's co-authors include Richard Koch, Shoji Yano, Colleen Azen, Sandra C. Van Calcar, Flemming Güttler, Rani H. Singh, Ann B. Moser, Patricia L. Splett, Dianne M. Frazier and Shideh Mofidi and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Ophthalmology.

In The Last Decade

Kathryn Moseley

26 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Moseley United States 17 672 416 410 178 137 26 833
Elaina Jurecki United States 15 755 1.1× 426 1.0× 547 1.3× 208 1.2× 133 1.0× 31 899
E. Mönch Germany 13 519 0.8× 347 0.8× 287 0.7× 84 0.5× 97 0.7× 37 686
Annemiek M. J. van Wegberg Netherlands 10 1.0k 1.5× 611 1.5× 628 1.5× 210 1.2× 188 1.4× 26 1.2k
María Antònia Vilaseca Spain 20 652 1.0× 639 1.5× 269 0.7× 251 1.4× 139 1.0× 45 1.1k
C. R. Roe United States 9 524 0.8× 409 1.0× 164 0.4× 72 0.4× 182 1.3× 10 691
H. D. Bakker Netherlands 14 354 0.5× 267 0.6× 175 0.4× 83 0.5× 82 0.6× 28 556
M. Blaskovics United States 12 340 0.5× 248 0.6× 146 0.4× 86 0.5× 98 0.7× 21 534
F. X. Coudé France 16 484 0.7× 292 0.7× 183 0.4× 52 0.3× 177 1.3× 33 709
F. Güttler Denmark 9 389 0.6× 270 0.6× 226 0.6× 76 0.4× 49 0.4× 15 491
Pascale Delonlay France 11 255 0.4× 304 0.7× 100 0.2× 33 0.2× 62 0.5× 13 530

Countries citing papers authored by Kathryn Moseley

Since Specialization
Citations

This map shows the geographic impact of Kathryn Moseley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Moseley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Moseley more than expected).

Fields of papers citing papers by Kathryn Moseley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Moseley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Moseley. The network helps show where Kathryn Moseley may publish in the future.

Co-authorship network of co-authors of Kathryn Moseley

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Moseley. A scholar is included among the top collaborators of Kathryn Moseley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Moseley. Kathryn Moseley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yano, Shoji, Kathryn Moseley, & Colleen Azen. (2017). Detection of early end-organ damage by endothelial dysfunction with reactive hyperemia-digital peripheral arterial tonometry in patients with Fabry disease. Molecular Genetics and Metabolism. 120(1-2). S143–S143. 1 indexed citations
3.
Singh, Rani H., Amy Cunningham, Shideh Mofidi, et al.. (2016). Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach. Molecular Genetics and Metabolism. 118(2). 72–83. 88 indexed citations
4.
5.
Yano, Shoji, Kathryn Moseley, & Colleen Azen. (2014). Melatonin and Dopamine as Biomarkers to Optimize Treatment in Phenylketonuria: Effects of Tryptophan and Tyrosine Supplementation. The Journal of Pediatrics. 165(1). 184–189.e1. 22 indexed citations
6.
Singh, Rani H., Fran Rohr, Dianne M. Frazier, et al.. (2014). Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genetics in Medicine. 16(2). 121–131. 140 indexed citations
7.
Berry, Susan A., Christine Brown, Mitzie Grant, et al.. (2013). Newborn screening 50 years later: access issues faced by adults with PKU. Genetics in Medicine. 15(8). 591–599. 92 indexed citations
8.
Yano, Shoji, Kathryn Moseley, & Colleen Azen. (2012). Large Neutral Amino Acid Supplementation Increases Melatonin Synthesis in Phenylketonuria: A New Biomarker. The Journal of Pediatrics. 162(5). 999–1003. 31 indexed citations
9.
Moseley, Kathryn, et al.. (2010). Maternal isovaleric acidemia: Observation of distinctive changes in plasma amino acids and carnitine profiles during pregnancy. Clinica Chimica Acta. 411(23-24). 2101–2103. 6 indexed citations
10.
Yano, Shoji, Berivan Baskin, Abdolreza Bagheri, et al.. (2010). Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations. Clinical Genetics. 80(5). 466–471. 25 indexed citations
11.
Edwards, Rebecca L., et al.. (2009). Long‐term neurodevelopmental effects of early detection and treatment in a 6‐year‐old patient with argininaemia diagnosed by newborn screening. Journal of Inherited Metabolic Disease. 32(S1). 197–200. 14 indexed citations
12.
Koch, Richard, Kathryn Moseley, & Flemming Güttler. (2005). Tetrahydrobiopterin and maternal PKU. Molecular Genetics and Metabolism. 86. 139–141. 29 indexed citations
13.
Matalon, Reuben, Richard Koch, Kimberlee Michals‐Matalon, et al.. (2004). Biopterin responsive phenylalanine hydroxylase deficiency. Genetics in Medicine. 6(1). 27–32. 50 indexed citations
15.
Ianchulev, Tsontcho, et al.. (2003). Optic nerve atrophy in propionic acidemia. Ophthalmology. 110(9). 1850–1854. 22 indexed citations
16.
Moats, Rex, Kathryn Moseley, Richard Koch, & Marvin D. Nelson. (2003). Brain Phenylalanine Concentrations in Phenylketonuria: Research and Treatment of Adults. PEDIATRICS. 112(Supplement_4). 1575–1579. 36 indexed citations
17.
Koch, Richard, Kathryn Moseley, Rex Moats, et al.. (2003). Danger of high‐protein dietary supplements to persons with hyperphenylalaninaemia. Journal of Inherited Metabolic Disease. 26(4). 339–342. 3 indexed citations
18.
Moseley, Kathryn, Richard Koch, & Ann B. Moser. (2002). Lipid Status and Long‐Chain Polyunsaturated Fatty Acid Concentrations in Adults and Adolescents with Phenylketonuria on Phenylalanine‐Restricted Diet. Journal of Inherited Metabolic Disease. 25(1). 56–64. 55 indexed citations
19.
Moats, Rex, Richard Koch, Kathryn Moseley, et al.. (2000). Brain phenylalanine concentration in the management of adults with phenylketonuria. Journal of Inherited Metabolic Disease. 23(1). 7–14. 44 indexed citations
20.
Koch, Richard, et al.. (1999). Long-Term Beneficial Effects of the Phenylalanine-Restricted Diet in Late-Diagnosed Individuals with Phenylketonuria. Molecular Genetics and Metabolism. 67(2). 148–155. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026